Primary Antibodies
Primary antibodies are immunoglobulins that recognize and bind to a specific antigen of interest with high affinity and specificity to purify, detect, and measure that antigen. Includes antibody pairs for specific biochemical applications.
All Primary Antibodies
(146,253)
Primary Antibody Matched Pairs
(33)
Protein Interaction Antibody Pairs
(5)
Protein Phosphorylation Antibody Pairs
(1)
Résultats de la recherche filtrée
Les produits de certains de nos fournisseurs ne s'affichent pas dans les résultats de la recherche filtrée. Veuillez
supprimer tous les filtres
pour voir ces produits.
1
–
15
de
133,029
résultats
Invitrogen™ Laminin alpha-3 Polyclonal Antibody
Greener Choice
Offers one or more environmental benefits itemized in the U.S. FTC Green Guides.
Learn More
Greener Choice
Offers one or more environmental benefits itemized in the U.S. FTC Green Guides.
Learn More
Offers one or more environmental benefits itemized in the U.S. FTC Green Guides.
Learn More
Rabbit Polyclonal Antibody
| Applications | ELISA,Immunohistochemistry (Paraffin),Western Blot,Immunocytochemistry |
|---|---|
| Type de produit | Antibody |
| Conjugué | Unconjugated |
| Espèces cibles | Human,Pig |
| Concentration | 0.5 mg/mL |
| Primaire ou secondaire | Primary |
| Forme | Liquid |
| Contenu et stockage | Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles. |
| État réglementaire | RUO |
| Numéro d’ordre du gène | Q16787 |
| Immunogène | Recombinant Laminin Alpha 3 (LAMa3) (Gln47-Leu296). |
| Expression | LAMA3 |
| Classification | Polyclonal |
| Identification génétique (Entrez) | 100511642, 3909 |
| Méthode de purification | Protein A |
| Espèces hôtes | Rabbit |
| Symboles de gène(s) | LAMA3 |
| Formule | PBS with 50% glycerol and 0.05% ProClin 300; pH 7.4 |
| Alias de gène | [a]3B; BM600; BM600 150kD subunit; E170; Epiligrin; Epiligrin 170 kDa subunit; epiligrin alpha 3 subunit; epiligrin subunit alpha; kalinin 165kD subunit; kalinin subunit alpha; LAM3, alpha-3 subunit; Lama3; Lama3B; laminin 5 alpha 3; laminin 5, alpha-3 subunit; laminin A3; laminin subunit alpha 3; laminin subunit alpha-3; laminin, alpha 3; laminin, alpha 3 (nicein (150kD), kalinin (165kD), BM600 (150kD), epilegrin); Laminin-5; laminin-5 alpha 3 chain; laminin-5 subunit alpha; Laminin-6 subunit alpha; laminin-7 subunit alpha; LAMNA; LOCS; nicein 150kD subunit; nicein subunit alpha; nicein, 150kDa |
| Antigène | Laminin alpha-3 |
Invitrogen™ SARS Coronavirus Spike Protein Polyclonal Antibody
Greener Choice
Offers one or more environmental benefits itemized in the U.S. FTC Green Guides.
Learn More
Greener Choice
Offers one or more environmental benefits itemized in the U.S. FTC Green Guides.
Learn More
Offers one or more environmental benefits itemized in the U.S. FTC Green Guides.
Learn More
Rabbit Polyclonal Antibody
| Applications | Western Blot |
|---|---|
| Type de produit | Antibody |
| Isotype | IgG |
| Conjugué | Unconjugated |
| Espèces cibles | Virus |
| Concentration | 1.0 mg/mL |
| Primaire ou secondaire | Primary |
| Forme | Liquid |
| Contenu et stockage | Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles. |
| État réglementaire | RUO |
| Immunogène | Synthetic peptide corresponding to amino acids 1124-1140 from the S (Spike glycoprotein) (Spike protein S2') for the Human SARS coronavirus. |
| Classification | Polyclonal |
| Méthode de purification | Antigen affinity chromatography |
| Espèces hôtes | Rabbit |
| Formule | PBS with 0.02% sodium azide |
| Alias de gène | Coronavirus; COVID; Covid 19; COVID19; COVID-19; SARS; SARS Coronavirus; SARS CoV; SARS CoV2; SARS CoV-2; SARS Spike Protein; SARS-CoV2; SARS-CoV-2 |
| Antigène | SARS Coronavirus Spike Protein |
Invitrogen™ Myogenin Recombinant Rabbit Monoclonal Antibody (JE60-39)
Rabbit Recombinant Monoclonal Antibody
| Applications | Western Blot,Immunocytochemistry |
|---|---|
| Type de produit | Antibody |
| Isotype | IgG |
| Conjugué | Unconjugated |
| Espèces cibles | Human,Mouse,Rat |
| Concentration | 1 mg/mL |
| Primaire ou secondaire | Primary |
| Forme | Liquid |
| Contenu et stockage | Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles. |
| État réglementaire | RUO |
| Numéro d’ordre du gène | P12979, P15173, P20428 |
| Immunogène | Synthetic peptide within human myogenin aa 1-50/224. |
| Expression | MYOG |
| Classification | Recombinant Monoclonal |
| Identification génétique (Entrez) | 17928, 29148, 4656 |
| Méthode de purification | Protein A |
| Espèces hôtes | Rabbit |
| Symboles de gène(s) | MYOG |
| Formule | TBS with 0.05% BSA, 40% glycerol and 0.05% sodium azide; pH 7.4 |
| Alias de gène | bHLHc3; Class C basic helix-loop-helix protein 3; MYF4; Myf-4; myo; MYOD1-related protein; MYOG; Myogenic factor 4; Myogenic factor-4; myogenin; myogenin (myogenic factor 4) |
| Clone | JE60-39 |
| Antigène | Myogenin |
| Applications | Immunohistochemistry (Paraffin),Multiplex Immunohistochemistry |
|---|---|
| Type de produit | Antibody |
| Isotype | IgG2b κ |
| Conjugué | Alexa Fluor 700 |
| Espèces cibles | Human |
| Concentration | 0.2 mg/mL |
| Primaire ou secondaire | Primary |
| Forme | Liquid |
| Contenu et stockage | 4°C, store in dark |
| État réglementaire | RUO |
| Numéro d’ordre du gène | P04637 |
| Immunogène | Recombinant human wild-type p53 protein expressed in E. coli. |
| Expression | Tp53 |
| Classification | Monoclonal |
| Identification génétique (Entrez) | 7157 |
| Méthode de purification | Protein A |
| Espèces hôtes | Mouse |
| Symboles de gène(s) | Tp53 |
| Formule | PBS with 0.5% BSA, 10% proprietary stabilizer and 0.05% sodium azide; pH 7.2 |
| Alias de gène | Antigen NY-CO-13; bbl; BCC7; bfy; bhy; cellular tumor antigen p53; Cys 51 Stop; EGK_08142; FLJ92943; HGNC11998; I79_002739; LFS1; Li-Fraumeni syndrome; mutant p53; mutant tumor protein 53; OTTMUSP00000006194; p44; p53; p53 cellular tumor antigen; p53 protein; p53 tumor suppressor; p53 tumor suppressor phosphoprotein; phosphoprotein p53; Tp53; tp53.L; transformation related protein 53; transformation-related protein 53; Trp248; Trp53; tumor protein 53; tumor protein p53; tumor protein p53 (Li-Fraumeni syndrome); tumor protein p53 L homeolog; tumor suppressor p53; tumor suppressor p53 phosphoprotein; tumor suppressor protein p53; tumor supressor p53; Tumour Protein p53; XELAEV_180196761mg; Xp53; Xrel3 |
| Clone | DO-7 |
| Antigène | p53 |
Invitrogen™ Pan Cytokeratin Monoclonal Antibody (AE1/AE3), Alexa Fluor™ 700
Mouse Monoclonal Antibody
| Applications | Immunohistochemistry (Paraffin),Multiplex Immunohistochemistry |
|---|---|
| Type de produit | Antibody |
| Isotype | IgG1 |
| Conjugué | Alexa Fluor 700 |
| Espèces cibles | Human |
| Concentration | 0.2 mg/mL |
| Primaire ou secondaire | Primary |
| Forme | Liquid |
| Contenu et stockage | 4°C, store in dark, DO NOT FREEZE! |
| État réglementaire | RUO |
| Numéro d’ordre du gène | P02533, P02538, P04264, P05783, P05787, P08727, P08729, P08779, P12035, P13645, P13646, P13647, P19012, P19013, P35908, Q01546, Q04695, Q7Z794 |
| Expression | KRT19 |
| Classification | Monoclonal |
| Identification génétique (Entrez) | 374454, 3848, 3849, 3850, 3851, 3852, 3853, 3855, 3856, 3858, 3860, 3861, 3866, 3868, 3872, 3875, 3880, 51350 |
| Méthode de purification | Affinity chromatography |
| Espèces hôtes | Mouse |
| Symboles de gène(s) | KRT1, KRT10, KRT13, KRT14, KRT15, KRT16, KRT17, KRT18, KRT19, KRT2, KRT3, KRT4, KRT5, Krt6a, KRT7, KRT76, KRT77, KRT8 |
| Formule | PBS with 0.5% BSA, 10% proprietary stabilizer and 0.05% sodium azide; pH 7.2 |
| Alias de gène | 2310016L08Rik; 3300001P10Rik; 39.1; 40-kDa keratin intermediate filament; 47 kDa cytokeratin; 56 kDa cytokeratin; 57kd keratin; 57kDa keratin; 58 kDa cytokeratin; 60-kDa keratin; 63kDa Keratin; 65 kDa cytokeratin; 67 kDa cytokeratin; AA960620; adult keratin; AI324768; AI528832; AI626930; AI663979; AL022697; alpha keratin; AU019895; AW108092; AW146334; basic epidermal type II cytokeratin (carboxy-terminal region, clone pUF164); BB005427; BCIE; BIE; Card2; cell proliferation-inducing gene 46 protein; CK 2e; CK1; CK-1; CK10; CK-10; CK13; CK-13; CK14; CK-14; CK15; CK-15; CK16; CK-16; CK-17; CK18; CK-18; CK19; CK-19; CK-1B; CK-2e; CK3; CK-3; CK4; CK-4; CK5; CK-5; ck55; CK6A; CK-6A; CK6C; CK-6C; CK6D; CK-6D; CK-6E; CK7; CK-7; CK8; CK-8; CYK18; CYK4; CYK8; CYKER; cytokeratin 1; cytokeratin 10; cytokeratin 13; cytokeratin 14; cytokeratin 15; cytokeratin 16; cytokeratin 18; cytokeratin 19; cytokeratin 3; cytokeratin 4; cytokeratin 5; cytokeratin 6A; cytokeratin 6C; cytokeratin 6D; cytokeratin 7; cytokeratin 8; cytokeratin 8 (370 AA); cytokeratin endo A; Cytokeratin endo B; cytokeratin otokeratin; cytokeratin type II; cytokeratin type II, component Ib/c; cytokeratin type II, component III; cytokeratin VIB; cytokeratin VII; cytokeratin-1; Cytokeratin-10; cytokeratin-13; Cytokeratin-14; cytokeratin-15; Cytokeratin-16; cytokeratin-17; Cytokeratin-18; cytokeratin-19; Cytokeratin-1B; Cytokeratin-2e; cytokeratin-3; Cytokeratin-4; cytokeratin-5; Cytokeratin-6A; cytokeratin-6B; cytokeratin-6C; Cytokeratin-6D; cytokeratin-6E; cytokeratin-7; Cytokeratin-8; cytokeratin-A; Cytoskeletal 57 kDa keratin; D130054E02Rik; D15Wsu77e; DDD; DDD1; ear specific cytokeratin; EBS2; ebs3; ebs4; EGK_03684; EGK_03685; EHK; EHK1; Endo B; EndoA; EndoC; epidermal keratin 10; epidermal keratin VII; epidermolysis bullosa simplex 2 Dowling-Meara/Kobner/Weber-Cockayne types; epidermolysis bullosa simplex, Dowling-Meara, Koebner; epidermolytic hyperkeratosis 1; epidermolytic hyperkeratosis; keratosis palmaris et plantaris; epithelial keratin 1; epithelial keratin 10; epithelial keratin 2e; Epithelial keratin-1; Epithelial keratin-2e; EPPK; fgk; fin and gill keratin; FNEPPK; focal non-epidermolytic palmoplantar keratoderma; GK-19; Hair alpha protein; HMWCK; Hom s 5; I79_019823; I79_021074; I79_023185; I79_024335; intermediate filament protein; K1; K10; K13; K14; K15; K16; K17; K18; K19; K1B; K1C1; K1CO; K1CP; K1CS; K2C7; K2C8; K2e; K3; K3 keratin; K4; K5; K6A; K6a keratin; K6C; K6D; K7; K77; K8; Ka10; Ka13; Ka14; Ka15; Ka16; Ka17; Ka19; kamp-keratin derived antimicrobial peptide; Kb1; Kb2; Kb4; Kb7; KDAMP; KER1; Ker10; Ker2; KERA; keratin; keratin 1; keratin 1 (epidermolytic hyperkeratosis); keratin 1, type II; keratin 10; keratin 10 (epidermolytic hyperkeratosis); keratin 10 (epidermolytic hyperkeratosis; keratosis palmaris et plantaris); keratin 10, type I; keratin 10, type I L homeolog; keratin 10, type I S homeolog; keratin 12, gene 2 S homeolog; keratin 13; keratin 13, type I; keratin 13, type I S homeolog; keratin 14; keratin 14 (epidermolysis bullosa simplex, Dowling-Meara, Koebner); keratin 14, type I; keratin 14, type I L homeolog; keratin 15; keratin 15, gene 1 S homeolog; keratin 15, type I; keratin 16; keratin 16 (focal non-epidermolytic palmoplantar keratoderma); keratin 16, type I; keratin 16, type I S homeolog; keratin 17; keratin 17 L homeolog; keratin 17, type I; keratin 17, type I L homeolog; keratin 18; keratin 18, type I; keratin 19; keratin 19 S homeolog; keratin 19 S homeolog; keratin 19; keratin 19, type I; Keratin 1B; keratin 2; keratin 2 (epidermal ichthyosis bullosa of Siemens); keratin 2 epidermis; keratin 2, type II; keratin 24; keratin 2A; keratin 2A (epidermal ichthyosis bullosa of Siemens); keratin 3; keratin 3, type II; keratin 4; keratin 4, type II; keratin 5; keratin 5 (epidermolysis bullosa simplex Dowling-Meara/Kobner/Weber-Cockayne types); keratin 5 (epidermolysis bullosa simplex, Dowling-Meara/Kobner/Weber-Cockayne types) |
| Clone | AE1/AE3 |
| Antigène | Pan Cytokeratin |
Invitrogen™ SMAD2 Recombinant Rabbit Monoclonal Antibody (31H15L4), Alexa Fluor™ Plus 488
Rabbit Recombinant Monoclonal Antibody
| Applications | Western Blot,Immunocytochemistry |
|---|---|
| Type de produit | Antibody |
| Isotype | IgG |
| Conjugué | Alexa Fluor Plus 488 |
| Espèces cibles | Human |
| Concentration | 1 mg/mL |
| Primaire ou secondaire | Primary |
| Forme | Liquid |
| Contenu et stockage | 4°C, store in dark, DO NOT FREEZE! |
| État réglementaire | RUO |
| Numéro d’ordre du gène | Q15796 |
| Expression | SMAD2 |
| Classification | Recombinant Monoclonal |
| Identification génétique (Entrez) | 4087 |
| Méthode de purification | Protein A/G |
| Espèces hôtes | Rabbit |
| Symboles de gène(s) | SMAD2 |
| Formule | Proprietary buffer with 0.008% Bromonitrodioxane, 0.008% Methylisothiazolone; pH 6.3-7.3 |
| Alias de gène | 7120426M23Rik; EGK_09664; hMAD-2; hSMAD2; JV18; JV18-1; MAD; MAD homolog 2; Mad protein homolog; Madh2; Madr2; Mad-related protein 2; MGC22139; MGC34440; mMad2; mother against DPP homolog 2; mothers against decapentaplegic homolog 2; Mothers against decapentaplegic-like protein 2; mothers against DPP homolog 2; pSMAD2; Sma- and Mad-related protein 2; SMAD; SMAD 2; SMAD family member 2; SMAD, mothers against DPP homolog 2; Smad2; Smad-2; Smad2Deltaexon3 |
| Clone | 31H15L4 |
| Antigène | SMAD2 |
Invitrogen™ SMAD2 Recombinant Rabbit Monoclonal Antibody (31H15L4), Alexa Fluor™ Plus 555
Rabbit Recombinant Monoclonal Antibody
| Applications | Flow Cytometry,Western Blot,Immunocytochemistry |
|---|---|
| Type de produit | Antibody |
| Isotype | IgG |
| Conjugué | Alexa Fluor Plus 555 |
| Espèces cibles | Human |
| Concentration | 1 mg/mL |
| Primaire ou secondaire | Primary |
| Forme | Liquid |
| Contenu et stockage | 4°C, store in dark, DO NOT FREEZE! |
| État réglementaire | RUO |
| Numéro d’ordre du gène | Q15796 |
| Expression | SMAD2 |
| Classification | Recombinant Monoclonal |
| Identification génétique (Entrez) | 4087 |
| Méthode de purification | Protein A/G |
| Espèces hôtes | Rabbit |
| Symboles de gène(s) | SMAD2 |
| Formule | Proprietary buffer with 0.008% Bromonitrodioxane, 0.008% Methylisothiazolone; pH 6.3-7.3 |
| Alias de gène | 7120426M23Rik; EGK_09664; hMAD-2; hSMAD2; JV18; JV18-1; MAD; MAD homolog 2; Mad protein homolog; Madh2; Madr2; Mad-related protein 2; MGC22139; MGC34440; mMad2; mother against DPP homolog 2; mothers against decapentaplegic homolog 2; Mothers against decapentaplegic-like protein 2; mothers against DPP homolog 2; pSMAD2; Sma- and Mad-related protein 2; SMAD; SMAD 2; SMAD family member 2; SMAD, mothers against DPP homolog 2; Smad2; Smad-2; Smad2Deltaexon3 |
| Clone | 31H15L4 |
| Antigène | SMAD2 |
Invitrogen™ SMAD2 Recombinant Rabbit Monoclonal Antibody (31H15L4), Alexa Fluor™ Plus 647
Rabbit Recombinant Monoclonal Antibody
| Applications | Flow Cytometry,Western Blot,Immunocytochemistry |
|---|---|
| Type de produit | Antibody |
| Isotype | IgG |
| Conjugué | Alexa Fluor Plus 647 |
| Espèces cibles | Human |
| Concentration | 1 mg/mL |
| Primaire ou secondaire | Primary |
| Forme | Liquid |
| Contenu et stockage | 4°C, store in dark, DO NOT FREEZE! |
| État réglementaire | RUO |
| Numéro d’ordre du gène | Q15796 |
| Expression | SMAD2 |
| Classification | Recombinant Monoclonal |
| Identification génétique (Entrez) | 4087 |
| Méthode de purification | Protein A/G |
| Espèces hôtes | Rabbit |
| Symboles de gène(s) | SMAD2 |
| Formule | Proprietary buffer with 0.008% Bromonitrodioxane, 0.008% Methylisothiazolone; pH 6.3-7.3 |
| Alias de gène | 7120426M23Rik; EGK_09664; hMAD-2; hSMAD2; JV18; JV18-1; MAD; MAD homolog 2; Mad protein homolog; Madh2; Madr2; Mad-related protein 2; MGC22139; MGC34440; mMad2; mother against DPP homolog 2; mothers against decapentaplegic homolog 2; Mothers against decapentaplegic-like protein 2; mothers against DPP homolog 2; pSMAD2; Sma- and Mad-related protein 2; SMAD; SMAD 2; SMAD family member 2; SMAD, mothers against DPP homolog 2; Smad2; Smad-2; Smad2Deltaexon3 |
| Clone | 31H15L4 |
| Antigène | SMAD2 |
Invitrogen™ CD4 Recombinant Rat Monoclonal Antibody (4SM95), Alexa Fluor™ Plus 647
Rat Recombinant Monoclonal Antibody
| Applications | Flow Cytometry,Immunohistochemistry (Paraffin),Immunocytochemistry |
|---|---|
| Type de produit | Antibody |
| Isotype | IgG1 κ |
| Conjugué | Alexa Fluor Plus 647 |
| Espèces cibles | Mouse |
| Concentration | 1 mg/mL |
| Primaire ou secondaire | Primary |
| Forme | Liquid |
| Contenu et stockage | 4°C, store in dark, DO NOT FREEZE! |
| État réglementaire | RUO |
| Numéro d’ordre du gène | P06332 |
| Expression | CD4 |
| Classification | Recombinant Monoclonal |
| Identification génétique (Entrez) | 12504 |
| Méthode de purification | Affinity chromatography |
| Espèces hôtes | Rat |
| Symboles de gène(s) | CD4 |
| Formule | Proprietary buffer with 0.008% Bromonitrodioxane, 0.008% Methylisothiazolone; pH 6.3-7.3 |
| Alias de gène | Activation B7-1 antigen; B7; B7.1; B7-1; BB1; B-lymphocyte activation antigen B7; CD28LG; CD28LG1; CD4; CD4 antigen; CD4 antigen (p55); CD4 antigen p55; Cd4 molecule; CD4 precursor; CD4 receptor; CD4, allele 1; cd4a; CD4mut; CD80; CD80 antigen (CD28 antigen ligand 1, B7-1 antigen); CD80 molecule; cell surface glycoprotein CD4; costimulatory factor CD80; costimulatory molecule variant IgV-CD80; CTLA-4 counter-receptor B7.1; fCD4; L3T4; LAB7; Leu-3; Ly-4; lymphocyte antigen CD4; lymphocyte antigen CD4 precursor; membrane protein; p55; T-cell differentiation antigen L3T4; T-cell surface antigen T4/Leu-3; T-cell surface glycoprotein CD4; T-cell surface glycoprotein CD4 precursor (T-cell surface antigen T4/Leu-3) (T-cell differentiation antigen L3T4); T-lymphocyte activation antigen CD80; W3/25; W3/25 antigen |
| Clone | 4SM95 |
| Antigène | CD4 |
| Applications | Flow Cytometry,Immunohistochemistry (Paraffin),Western Blot,Immunocytochemistry |
|---|---|
| Type de produit | Antibody |
| Isotype | IgG2a κ |
| Conjugué | Unconjugated |
| Espèces cibles | Human |
| Concentration | 1 mg/mL |
| Primaire ou secondaire | Primary |
| Forme | Liquid |
| Contenu et stockage | -20°C, Avoid Freeze/Thaw Cycles |
| État réglementaire | RUO |
| Numéro d’ordre du gène | P15391 |
| Expression | Cd19 |
| Classification | Recombinant Monoclonal |
| Identification génétique (Entrez) | 930 |
| Méthode de purification | Affinity chromatography |
| Espèces hôtes | Rat |
| Symboles de gène(s) | Cd19 |
| Formule | PBS with 0.09% sodium azide; pH 7.4 |
| Alias de gène | AW495831; B4; B-lymphocyte antigen CD19; B-lymphocyte surface antigen B4; Cd19; CD19 antigen; CD19 molecule; CVID3; differentiation antigen CD19; Leu-12; T-cell surface antigen Leu-12 |
| Clone | 6OMP31 |
| Antigène | CD19 |
| Applications | Flow Cytometry,Western Blot,Immunocytochemistry |
|---|---|
| Type de produit | Antibody |
| Isotype | IgG2a κ |
| Conjugué | Unconjugated |
| Espèces cibles | Mouse |
| Concentration | 1 mg/mL |
| Primaire ou secondaire | Primary |
| Forme | Liquid |
| Contenu et stockage | Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles. |
| État réglementaire | RUO |
| Numéro d’ordre du gène | Q00560 |
| Expression | IL6ST |
| Classification | Recombinant Monoclonal |
| Identification génétique (Entrez) | 16195 |
| Méthode de purification | Affinity chromatography |
| Espèces hôtes | Rat |
| Symboles de gène(s) | IL6ST |
| Formule | PBS with 0.09% sodium azide; pH 7.4 |
| Alias de gène | 5133400A03Rik; AA389424; Ac1055; BB405851; CD130; CD130 antigen; CDW130; D13Ertd699e; EGK_16499; Gp130; gp130 of the rheumatoid arthritis antigenic peptide-bearing soluble form; gp130, oncostatin M receptor; GP130-RAPS; IL-6; IL-6 receptor subunit beta; IL-6R subunit beta; IL-6RB; IL-6R-beta; IL6R-beta; IL6ST; interleukin 6 signal transducer; interleukin 6 signal transducer (gp130, oncostatin M receptor); interleukin 6 signal transducer receptor; interleukin receptor beta chain; interleukin-6 receptor subunit beta; Interleukin-6 signal transducer; interleukin-6 signal transducer receptor; membrane glycoprotein; membrane glycoprotein 130; membrane glycoprotein gp130; oncostatin-M receptor subunit alpha |
| Clone | KGP130 |
| Antigène | CD130 |
Invitrogen™ Phospho-mTOR (Ser2448) Recombinant Mouse Monoclonal Antibody (MRRBY)
Mouse Recombinant Monoclonal Antibody
| Applications | Flow Cytometry,Western Blot |
|---|---|
| Type de produit | Antibody |
| Isotype | IgG2a κ |
| Conjugué | Unconjugated |
| Espèces cibles | Human |
| Concentration | 1 mg/mL |
| Primaire ou secondaire | Primary |
| Forme | Liquid |
| Contenu et stockage | Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles. |
| État réglementaire | RUO |
| Numéro d’ordre du gène | P42345 |
| Expression | MTOR |
| Classification | Recombinant Monoclonal |
| Identification génétique (Entrez) | 2475 |
| Méthode de purification | Protein A/G |
| Espèces hôtes | Mouse |
| Symboles de gène(s) | MTOR |
| Formule | PBS with 0.09% sodium azide; pH 7.4 |
| Alias de gène | 2610315D21Rik; AI327068; angiopoietin-like factor CDT6; FK506 binding protein 12-rapamycin associated protein 1; FK506 binding protein 12-rapamycin associated protein 2; FK506-binding protein 12-rapamycin complex-associated protein 1; FKBP12-rapamycin complex-associated protein; FKBP12-rapamycin complex-associated protein 1; FKBP-rapamycin associated protein; FKBP-rapamycin associated protein (FRAP); FKBP-rapamycin-associated protein FRAP; flat; FRAP; FRAP1; FRAP2; Mammalian target of rapamycin; mechanistic target of rapamycin; mechanistic target of rapamycin (serine/threonine kinase); mechanistic target of rapamycin kinase; Mtor; m-TOR; mTORC1; Raft1; Rapamycin and FKBP12 target 1; rapamycin and FKBP12 target-1 protein; rapamycin associated protein FRAP2; rapamycin target protein 1; RAPT1; serine/threonine-protein kinase mTOR; SKS |
| Clone | MRRBY |
| Antigène | Phospho-mTOR (Ser2448) |
Invitrogen™ V5 Tag Recombinant Mouse Monoclonal Antibody (TCM5), Alexa Fluor™ Plus 555
Mouse Recombinant Monoclonal Antibody
| Applications | Flow Cytometry,Western Blot,Immunocytochemistry |
|---|---|
| Type de produit | Antibody |
| Isotype | IgG2b κ |
| Conjugué | Alexa Fluor Plus 555 |
| Espèces cibles | Tag |
| Concentration | 1.0 mg/mL |
| Primaire ou secondaire | Primary |
| Forme | Liquid |
| Contenu et stockage | 4°C, store in dark, DO NOT FREEZE! |
| État réglementaire | RUO |
| Classification | Recombinant Monoclonal |
| Méthode de purification | Protein A/G |
| Espèces hôtes | Mouse |
| Formule | Proprietary buffer with 0.008% Bromonitrodioxane, 0.008% Methylisothiazolone; pH 6.8 |
| Alias de gène | simian virus 5 antibody; SPV5gp2; sv5; V5; v-5; V5 Epitope Tag |
| Clone | TCM5 |
| Antigène | V5 Tag |